At a Glance
- Tasks: Lead innovative drug discovery projects using cutting-edge biophysical assays and technologies.
- Company: Join UCB, a global biopharmaceutical leader focused on neurology and immunology.
- Benefits: Enjoy a supportive culture, hybrid work options, and opportunities for personal growth.
- Other info: Mentorship opportunities and a dynamic environment for career development.
- Why this job: Make a real impact on patients' lives through scientific innovation and collaboration.
- Qualifications: PhD or Master's in a relevant field with expertise in SPR and biophysical assays.
The predicted salary is between 63000 - 77000 £ per year.
We are looking for a Principal Scientist – SPR and Biophysical Assays who is innovative, collaborative, and scientifically rigorous to join our team in In Vitro Pharmacology, based at our UCB campus in Slough, Berkshire, United Kingdom.
As a Principal Scientist, you will play a key role in advancing drug discovery programs across Patient Solutions by generating critical SPR (Surface Plasmon Resonance) and biophysical assay data. You will provide scientific leadership, influence project decisions, and help shape the future of biophysical screening capabilities. You will contribute from target validation through candidate selection while driving innovation, continuous improvement, and the adoption of new technologies.
You will work within the In Vitro Pharmacology organization and collaborate closely with multidisciplinary project teams across research sites. You will partner with scientists working on antibodies, small molecules, and emerging therapeutic modalities while acting as a technical expert in SPR and biophysical assays. You will also mentor junior scientists and help strengthen capabilities across the wider discovery community.
What you will do:
- You will design, develop, and optimize SPR and biophysical assays for therapeutic discovery programs.
- You will generate binding, affinity, kinetic, competition, and epitope binning data to support decisions.
- You will autonomously lead complex studies addressing challenging scientific questions and novel therapeutic modalities.
- You will champion new technologies, automation solutions, and continuous improvement initiatives within the team.
- You will present high-quality scientific data and influence project strategy across multidisciplinary teams.
- You will mentor scientists, share expertise, and contribute to a collaborative research environment.
- Provide coaching and scientific guidance to junior team members, supporting their development and contributing to a collaborative learning environment.
- Where appropriate, contribute to people leadership activities, including mentoring, onboarding, and supporting the development of fellow scientists.
Interested? For this role, we are looking for the following education, experience, and skills:
- PhD, Master's degree, or equivalent experience in a relevant scientific discipline.
- Extensive expertise applying SPR to antibody and/or small molecule discovery programs.
- Proven experience developing, optimizing, and validating complex biophysical assays independently.
- Strong understanding of drug discovery processes and therapeutic candidate progression.
- Excellent communication skills with experience influencing multidisciplinary scientific teams.
- Adaptable, highly organized, and enthusiastic about implementing innovative technologies and approaches.
- Experience mentoring, coaching, or supporting the development of scientists is highly valued.
- Previous team leadership or line management experience would be advantageous but is not essential.
- Demonstrated ability to influence, guide, and develop colleagues within a scientific environment is appreciated.
At UCB, we are committed to building an inclusive environment where everyone can thrive and contribute their unique perspectives. If you are passionate about advancing innovative medicines through cutting-edge biophysical sciences, we would love to hear from you.
Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9,000 people in all four corners of the globe, inspired by patients and driven by science.
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential. At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.
UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws. Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on EMEA-Reasonable_Accommodation@ucb.com. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.
Principal scientist employer: Ucb Group
UCB is an exceptional employer that fosters a collaborative and innovative work culture, where employees are encouraged to push boundaries and create meaningful value for patients. Located in Slough, our hybrid-first approach allows for flexibility while working alongside experienced scientists in a supportive environment that prioritises personal growth and career development. Join us to be part of a team that values inclusivity and empowers you to make your mark in the biopharmaceutical industry.